Albumin fusion interferon α-2b(Zhejiang Deqing Anping Bio-Pharma)
白蛋白融合干扰素α-2b（浙江德清安平生物）
Report date: 2025/06/26 10:43:51
Base Information
Drug NameAlbumin fusion interferon α-2b(Zhejiang Deqing Anping Bio-Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesZhejiang Deqing Anping Bio-Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesZhejiang Deqing Anping Bio-Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A